Style | Citing Format |
---|---|
MLA | Moghadam SO, et al.. "Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones." Infection and Drug Resistance, vol. 13, no. , 2020, pp. 1583-1592. |
APA | Moghadam SO, Afshar D, Nowroozi MR, Behnamfar A, Farzin A (2020). Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones. Infection and Drug Resistance, 13(), 1583-1592. |
Chicago | Moghadam SO, Afshar D, Nowroozi MR, Behnamfar A, Farzin A. "Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones." Infection and Drug Resistance 13, no. (2020): 1583-1592. |
Harvard | Moghadam SO et al. (2020) 'Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones', Infection and Drug Resistance, 13(), pp. 1583-1592. |
Vancouver | Moghadam SO, Afshar D, Nowroozi MR, Behnamfar A, Farzin A. Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones. Infection and Drug Resistance. 2020;13():1583-1592. |
BibTex | @article{ author = {Moghadam SO and Afshar D and Nowroozi MR and Behnamfar A and Farzin A}, title = {Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones}, journal = {Infection and Drug Resistance}, volume = {13}, number = {}, pages = {1583-1592}, year = {2020} } |
RIS | TY - JOUR AU - Moghadam SO AU - Afshar D AU - Nowroozi MR AU - Behnamfar A AU - Farzin A TI - Molecular Epidemiology of Carbapenemase-Producing Pseudomonas Aeruginosa Isolated From an Iranian University Hospital: Evidence for Spread of High-Risk Clones JO - Infection and Drug Resistance VL - 13 IS - SP - 1583 EP - 1592 PY - 2020 ER - |